Sowell Financial Services LLC Enanta Pharmaceuticals Inc Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 13, 2021	SELL	$41.16 - $47.47 $1,646 - $1,898	-40 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$43.36 - $53.53 $3,121 - $3,854	-72 Reduced 64.29%	40 $2,000
Q2 2020 Aug 13, 2020	SELL	$46.37 - $57.58 $19,104 - $23,722	-412 Reduced 78.63%	112 $6,000
Q1 2020 May 12, 2020	SELL	$40.22 - $62.0 $9,773 - $15,066	-243 Reduced 31.68%	524 $27,000
Q4 2019 Feb 07, 2020	BUY	$57.95 - $66.61 $44,447 - $51,089	767 New	767 $47,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.